AVANIR PHARMACEUTICALS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$97.1M

442 transactions

Summary

AVANIR PHARMACEUTICALS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.1MSales: $80.1M40 insiders

Date	Insider	Type	Value
2014-12-15	Katkin Keith(President and CEO)	Sell	$3.3M
2014-12-17	Katkin Keith(President and CEO)	Sell	$1.1M
2014-12-15	Katkin Keith(President and CEO)	Sell	$339K
2014-12-18	Siffert Joao MD(SVP, R&D)	F	$326K
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	Sell	$296K
2014-12-18	Siffert Joao MD(SVP, R&D)	Sell	$262K
2014-12-15	Katkin Keith(President and CEO)	M	$242K
2014-11-28	PALEKAR ROHAN(SVP & Chief Commercial Officer)	Sell	$225K
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	Sell	$212K
2014-12-18	OCAMPO CHRISTINE(Vice President, Finance)	Sell	$98K
2014-12-18	Siffert Joao MD(SVP, R&D)	M	$84K
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	M	$73K
2014-12-15	Katkin Keith(President and CEO)	M	$72K
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	M	$32K
2014-12-18	Siffert Joao MD(SVP, R&D)	M	$0
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	M	$0
2014-12-16	OCAMPO CHRISTINE(Vice President, Finance)	M	$0
2014-12-15	Katkin Keith(President and CEO)	M	$0
2014-12-15	Katkin Keith(President and CEO)	M	$0
2014-11-28	PALEKAR ROHAN(SVP & Chief Commercial Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

AVANIR PHARMACEUTICALS, INC. — Contributions, Lobbying & Contracts | Poliscope